Company
Zhengye Biotechnology Holding Ltd (ZYBT)
Standardized SEC financial data for Zhengye Biotechnology Holding Ltd — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001975641 · NASDAQ · Pharmaceutical Preparations.
Gross margin
20.5%
Operating margin
-60.6%
Net margin
-60.0%
Revenue growth (YoY)
-37.6%
Return on equity
-22.8%
ROIC
-20.9%
Free cash flow
¥12.3M
Debt / equity
0.03×
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| ¥ | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | ¥260.3M | ¥211.7M | ¥186.4M | ¥116.4M |
| Cost of revenue | ¥112.4M | ¥94.1M | ¥95.1M | ¥92.5M |
Balance sheet
| ¥ | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Cash & equivalents | ¥6.3M | ¥9.7M | ¥27.2M | ¥18.6M | ¥50.3M |
| Inventory | — | — |
Cash flow
| ¥ | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Operating cash flow | ¥17.3M | ¥48.2M | ¥41.0M | ¥13.3M |
| Capital expenditures | ¥27.3M | ¥7.4M | ¥13.6M | ¥1.0M |
Get ZYBT data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/ZYBT/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/ZYBT/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"